tiprankstipranks
Asahi Kasei Corporation (JP:3407)
:3407
Want to see JP:3407 full AI Analyst Report?

Asahi Kasei (3407) AI Stock Analysis

4 Followers

Top Page

JP:3407

Asahi Kasei

(3407)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
¥1,843.00
▼(-0.14% Downside)
Action:Reiterated
Date:08/01/26
The score is primarily supported by improved financial performance versus the prior loss year and a reasonable valuation (P/E 12.1 with a ~2.44% dividend yield). Offsetting these positives are weaker near-term technicals (price below the 20- and 50-day averages) and cash-flow quality concerns, with free cash flow declining and trailing reported earnings.
Positive Factors
Diversified business model
Operating across materials, housing and healthcare creates durable revenue diversification. Cyclical exposure in chemicals is balanced by recurring housing services and healthcare products, lowering firm-level volatility and enabling cross-segment capital allocation and long-term resilience.
Negative Factors
Modest revenue growth
Low organic revenue growth indicates mature end markets and limited top-line momentum. Over a 2–6 month horizon this constrains operating-leverage gains and makes long-term EPS expansion more reliant on margin improvement, cost control or M&A to generate meaningful growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified business model
Operating across materials, housing and healthcare creates durable revenue diversification. Cyclical exposure in chemicals is balanced by recurring housing services and healthcare products, lowering firm-level volatility and enabling cross-segment capital allocation and long-term resilience.
Read all positive factors

Asahi Kasei (3407) vs. iShares MSCI Japan ETF (EWJ)

Asahi Kasei Business Overview & Revenue Model

Company Description
Asahi Kasei Corporation is a prominent Japanese enterprise operating globally in the manufacturing, processing, and distribution of a broad spectrum of products, primarily rooted in chemical science. Its diverse operations are strategically organi...
How the Company Makes Money
Asahi Kasei primarily makes money by selling products and services across three major business areas: (1) Materials: revenue is generated from manufacturing and selling basic and specialty chemicals, polymer and performance materials (e.g., engine...

Asahi Kasei Financial Statement Overview

Summary
Financials show a clear post-2023 recovery with improved profitability (TTM net margin ~6.1%, EBIT margin ~8.8%) and a healthier ROE (~9.5%). However, top-line growth is modest (TTM ~2.9%) and cash-flow quality is a key watch item: free cash flow is positive (~¥88B) but down ~19.6% and only ~29% of net income, indicating weaker conversion and/or higher reinvestment needs.
Income Statement
74
Positive
Balance Sheet
67
Positive
Cash Flow
58
Neutral
BreakdownTTMMar 2026Mar 2026Mar 2025Mar 2024Mar 2023
Income Statement
Total Revenue3.16T3.07T3.04T2.78T2.73T2.46T
Gross Profit1.06T1.01T908.86B849.21B804.77B796.97B
EBITDA481.42B423.40B389.80B218.49B120.65B366.89B
Net Income192.84B158.79B135.00B43.81B-91.95B161.88B
Balance Sheet
Total Assets4.46T4.14T4.02T3.66T3.45T3.35T
Cash, Cash Equivalents and Short-Term Investments387.36B377.02B393.47B338.11B251.18B244.64B
Total Debt1.16T1.01T1.20T955.56B974.75B777.22B
Total Liabilities2.26T1.97T2.10T1.81T1.76T1.63T
Stockholders Equity2.12T2.09T1.86T1.81T1.66T1.69T
Cash Flow
Free Cash Flow87.97B109.43B99.81B147.59B-61.17B41.02B
Operating Cash Flow300.70B303.10B301.49B295.30B90.80B183.27B
Investing Cash Flow-270.41B-88.87B-364.84B-142.60B-212.09B-221.02B
Financing Cash Flow-68.39B-263.35B128.25B-94.33B110.28B42.32B

Asahi Kasei Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
¥11.36T22.6010.90%1.58%0.62%-2.72%
64
Neutral
¥2.46T12.128.13%2.28%4.03%61.70%
64
Neutral
¥853.12B20.485.11%3.52%-4.09%-26.93%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
¥2.27T69.825.27%0.47%-3.97%-4.31%
57
Neutral
¥1.55T-19.580.66%2.81%-7.96%106.67%
54
Neutral
¥846.63B14.046.28%2.51%-10.66%58.38%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3407
Asahi Kasei
1,722.50
676.77
64.72%
JP:4188
Mitsubishi Chemical Holdings
1,188.00
434.49
57.66%
JP:4063
Shin-Etsu Chemical Co
5,800.00
1,520.44
35.53%
JP:4004
Resonac Holdings Corporation
13,725.00
10,124.72
281.22%
JP:4005
Sumitomo Chemical Co
521.30
164.20
45.98%
JP:4042
Tosoh
2,710.50
522.38
23.87%

Asahi Kasei Corporate Events

Asahi Kasei Q1 Profit Soars, Lifts Interim Dividend on Strong Core Businesses
Jul 31, 2026
Asahi Kasei reported a sharp year‑on‑year jump in first‑quarter fiscal 2026 operating income, driven by steady growth in its pharmaceuticals, critical care, and electronics businesses and a favorable inventory valuation effect in...
Asahi Kasei Delivers Strong Q1 FY2026 Results and Confirms Higher Dividend Outlook
Jul 31, 2026
Asahi Kasei reported a strong start to fiscal 2026, with first-quarter net sales up 11.9% year on year and operating income surging 51.5%, while net income attributable to owners of the parent jumped 172.7% amid a swing to positive comprehensive i...
Asahi Kasei Advances Share Buyback, Plans Cancellation of Repurchased Stock
Jul 1, 2026
Asahi Kasei Corp., a major Japanese manufacturer in chemicals and industrial materials, maintains an active presence in domestic capital markets and uses share repurchases as a tool to optimize its balance sheet and enhance shareholder value.The c...
Asahi Kasei Advances Share Buyback Under ¥40 Billion Authorization
Jun 1, 2026
Asahi Kasei Corp. reported progress on its ongoing share repurchase program authorized by the board in November 2025, acquiring 4,513,200 common shares for about ¥7.8 billion between May 1 and May 31, 2026. This buyback is part of a broader m...
Asahi Kasei Targets Third Straight Record Operating Profit as Portfolio Shift Pays Off
May 12, 2026
Asahi Kasei reported fiscal 2025 operating income of ¥231.2 billion, up 9.1% year on year, and net income of ¥158.8 billion, up 17.6%, achieving a record-high operating profit for the second straight year before goodwill amortization. Gr...
Asahi Kasei to Restructure Mizushima Derivatives Operations for Profitability and Carbon Goals
May 12, 2026
Asahi Kasei will reconfigure certain derivatives operations at its Mizushima Works to improve profitability by fiscal 2030, focusing on consolidating low-utilization businesses across the industry to raise operating rates and secure a more robust ...
Asahi Kasei Lifts Profit, Strengthens Balance Sheet and Dividends in Fiscal 2025
May 12, 2026
Asahi Kasei reported fiscal 2025 consolidated net sales of ¥3.07 trillion, up 1.2%, with operating income rising 9.1% to ¥231.2 billion and net income attributable to shareholders climbing 17.6% to ¥158.8 billion, reflecting improve...
Asahi Kasei to Exit Key Petrochemical Lines at Mizushima, Shift Toward Low-Carbon Basics
May 12, 2026
Asahi Kasei will reconfigure derivatives operations at its Mizushima Works by fiscal 2030, discontinuing domestic production of styrene monomer and low- and high-density polyethylene after decades of supply, as persistently low operating rates and...
Asahi Kasei Raises Dividend and Plans Further Payout Increase for FY 2027
May 12, 2026
Asahi Kasei’s board has approved an increased year-end dividend of ¥22 per share for the fiscal year ended March 31, 2026, up from the prior forecast of ¥20, bringing the total annual dividend to ¥42 including the interim payo...
Asahi Kasei Reports No Share Buybacks Yet Under ¥40 Billion Repurchase Plan
May 1, 2026
Asahi Kasei Corp., a diversified Japanese chemicals and materials group, has been implementing an authorized share repurchase framework as part of its broader capital allocation and shareholder return policies. The program, approved by the board i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 01, 2026